Virology
Hepatitis C seropositivity predicts mortality in HIV-coinfected patients
Published in AIDS Weekly, August 29th, 2005
"We examined the effect of hepatitis C virus (HCV) seropositivity on risk of death among people receiving their first antiretroviral treatment (ART) for HIV infection. In British Columbia, the HIV/AIDS Drug Treatment Program is the only source of free ART. Patients who initiated a triple-drug ART regimen between July 31, 1996, and July 31, 2000, were included if they were ART-naive and had baseline HCV serological data," scientists writing in the Canadian Medical Association Journal report.
"Outcomes of interest for survival analysis were deaths from natural and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-08-29)
More Articles from AIDS Weekly
- HIV/AIDS Diagnostics
Real-time RT-PCR diagnoses/monitors HIV-1 infection in resource-poor setting - HIV/AIDS Pathogenesis
Myeloid/plasmacytoid DCs transfer HIV-1 preferentially to Ag-specific CD4+ cells - HIV/AIDS Pathogenesis
Nanobacteria could promote genetic diversity in HIV - HIV/AIDS Research
Research shows random fluctuations in gene expression impacts HIV cells - HIV/AIDS Therapy
New approach has potential to treat latent HIV infection - Adverse Drug Reaction
Epidemiology study reports new info on hypersensitivity reactions to Abacavir - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
